| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/06/1992 | WO1992001453A1 Solid preparation |
| 02/06/1992 | WO1992001452A1 Enzyme inactivators |
| 02/06/1992 | WO1992001442A1 Stable pharmaceutical compositions containing a fibroblast growth factor |
| 02/06/1992 | WO1992001441A1 Stable formulation of active substance |
| 02/06/1992 | WO1992001440A1 Trans-mucosal drug preparations and trans-mucosal administration |
| 02/06/1992 | DE4124481A1 Solid oral ifosfamide dosage forms |
| 02/06/1992 | CA2087596A1 Products and processes for the treatment of the alimentary canal |
| 02/06/1992 | CA2087430A1 Stable pharmaceutical compositions containing a fibroblast growth factor |
| 02/06/1992 | CA2086527A1 Polymeric drug delivery system |
| 02/05/1992 | EP0470047A1 Sustained release formulations |
| 02/05/1992 | EP0469983A1 Peroxyacid-clathrates, their preparation and their uses |
| 02/05/1992 | EP0469520A2 Polyactide preparation and purification |
| 02/05/1992 | EP0469440A1 Solid oral administration forms containing ifosfamide as active agent |
| 02/05/1992 | EP0191772B1 Acid-cleavable compound |
| 02/05/1992 | CN1058341A Composition and method for topical treatment of damaged or diseased tissue |
| 02/04/1992 | WO1992002254A1 Microcapsules having a combined atelocollagen/polyholoside wall coagulated by a divalent cation |
| 02/04/1992 | US5086077 Endermic medicament with a gel base |
| 02/04/1992 | US5086075 Therapeutic compositions containing benzoyl peroxide |
| 02/04/1992 | US5086068 Immunochemical detection of hypoxia in normal and tumor tissue |
| 02/04/1992 | US5086041 Methods of using prolonged release somatotropin compositions |
| 02/04/1992 | US5085869 Wet granulation, low water solubility with microcrystalline or microfine cellulose |
| 02/04/1992 | US5085868 Microencapsulated with wax coatings in nonaqueous oil; masking unpleasant taste, sustained release, stability |
| 02/04/1992 | US5085867 Method for treating gastric ulcer with sulglycotide and hydrophilic polymer |
| 02/04/1992 | CA2087955A1 Microcapsules having a combined atelocollagen/polyholoside wall |
| 02/04/1992 | CA1295250C Process to prepare solid products containing oil-soluble substance |
| 02/04/1992 | CA1295249C Process to prepare solid products containing oil-soluble substance |
| 02/04/1992 | CA1295248C Powdery compound emulsifier, and its preparation and use |
| 02/04/1992 | CA1295247C Sustained release capsule |
| 02/04/1992 | CA1295245C Stable formulation of biologically active proteins for parenteral injection |
| 02/04/1992 | CA1295242C FORMULATIONS SUITABLE FOR THE STABILISATION OF .alpha.-INTERFERON |
| 01/31/1992 | WO1992002497A1 Peroxyacid clathrates, their production and use |
| 01/31/1992 | CA2066050A1 Peroxyacid clathrates; process for preparing the same and their use |
| 01/30/1992 | DE4023593A1 Use of mixts. of poly:glycerol fatty acid ester(s) |
| 01/29/1992 | EP0468929A2 Stabilized pharmaceutical compositions |
| 01/29/1992 | EP0468856A1 Solubilizing and dispersant compounds, process for preparation and compositions containing them |
| 01/29/1992 | EP0468637A1 In vivo targeting with bifunctional antibodies |
| 01/29/1992 | EP0468392A1 Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained |
| 01/29/1992 | EP0468232A2 Suspending syrups |
| 01/29/1992 | EP0467954A1 Preparation of liposome and lipid complex compositions. |
| 01/29/1992 | EP0318560B1 antipsoriatic pharmaceutical composition and process for the preparation |
| 01/29/1992 | CN1058149A Stabilized fibroblast growth factor composition |
| 01/28/1992 | US5084560 Immunoconjugates and methods for their use in tumor therapy |
| 01/28/1992 | US5084556 A polypeptide conjugated to a cytotoxic agent as an anticancer agent |
| 01/28/1992 | US5084553 Copolymers of lactic acid and tartaric acid, the production and the use thereof |
| 01/28/1992 | US5084509 Peptides or proteins bound to aminoalkyl polydimethylacrylamide for immunology |
| 01/28/1992 | US5084441 Acetylated low density lipoproteins: a delivery system to phagocytic cells for stimulating immunologic response and host resistance |
| 01/28/1992 | US5084276 Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation |
| 01/28/1992 | US5084267 Sustained release compositions for treating periodontal disease |
| 01/28/1992 | US5084266 Method for tumor imaging utilizing a labelled tumor specific antibody and a non-tumor reactive antibody |
| 01/28/1992 | CA2047861A1 Sustained release formulations |
| 01/28/1992 | CA1294878C Composition for the extemporary preparation of formulations for topical applications for pharmaceutical and cosmetic use |
| 01/28/1992 | CA1294877C Anti-inflammatory cream composition |
| 01/25/1992 | WO1992001469A1 A composition providing improved clearance of bioactive substances from the bloodstream |
| 01/25/1992 | CA2087971A1 Composition providing improved clearance of bioactive substances from the bloodstream |
| 01/24/1992 | CA2047572A1 Suspending syrups |
| 01/24/1992 | CA2047540A1 Continuous release pharmaceutical compositions |
| 01/23/1992 | WO1992000746A1 Reduction or prevention of skin irritation by drugs |
| 01/23/1992 | WO1992000745A1 Collagen-based viscoelastic solution for visco-surgery |
| 01/23/1992 | WO1992000732A1 Therapeutical composition and process for its preparation |
| 01/23/1992 | WO1992000707A1 Topical ophthalmic suspensions |
| 01/23/1992 | DE4023241A1 Stabile wirkstoff-formulierung Stable drug-formulation |
| 01/23/1992 | CA2086014A1 Collagen-based viscoelastic solution for visco-surgery |
| 01/22/1992 | EP0467838A2 Process for preparing an injectable liposome dispersion |
| 01/22/1992 | EP0467536A2 Method of treating bladder cancer cells |
| 01/22/1992 | EP0467416A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 01/22/1992 | EP0467389A2 Drug delivery system involving interaction between protein or polypeptide and hydrophobic biodegradable polymer |
| 01/22/1992 | EP0466816A1 Method for enhancing transmembrane transport of exogenous molecules |
| 01/22/1992 | CN1057960A Delay galenic parenteral form for injection |
| 01/21/1992 | WO1992001474A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 01/21/1992 | US5082927 Genetic engineering, immunology |
| 01/21/1992 | US5082866 Biodegradable absorption enhancers |
| 01/21/1992 | US5082864 Stabilized solutions of psychotropic agents |
| 01/21/1992 | US5082863 Bactericide, veterinary use |
| 01/21/1992 | CA2087163A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 01/21/1992 | CA2047482A1 Solid pharmaceutical composition |
| 01/21/1992 | CA1294551C Sustained release fluoride composition |
| 01/21/1992 | CA1294548C2 Dehydrated liposomes |
| 01/20/1992 | CA2050635A1 Class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties, and vaccines containing same |
| 01/19/1992 | WO1992001475A1 Compositions based on active principles of hydrophobic medicaments solubilizable in an aqueous solvent |
| 01/19/1992 | CA2087536A1 Compositions based on active ingredients of hydrophobic drugs that can be sulubilized in an aqueous solvent |
| 01/18/1992 | CA2047023A1 Process for the production of an injectable liposome dispersion |
| 01/15/1992 | EP0466566A2 Coated solid medicament form having releasebility in large intestine |
| 01/15/1992 | EP0466300A2 Biocompatible viscoelastic gel slurries, their preparation and use |
| 01/15/1992 | EP0466200A1 Aminocarboxylic acids and derivatives thereof |
| 01/15/1992 | EP0466038A1 Water-dispersible polyene antifungal complexes |
| 01/15/1992 | EP0465992A1 High solids low viscosity polysaccharide composition |
| 01/15/1992 | EP0465744A1 Formulations for sustained release dressings and their use |
| 01/15/1992 | EP0465633A1 C4 binding protein fusion proteins |
| 01/15/1992 | EP0465588A1 The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions |
| 01/15/1992 | EP0465580A1 Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs |
| 01/15/1992 | EP0465550A1 Pharmaceutical lipid composition for parenteral nutrition. |
| 01/15/1992 | EP0465529A1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 01/15/1992 | EP0465513A1 FORMULATIONS FOR STABILIZING OF IgM ANTIBODIES |
| 01/14/1992 | WO1992000988A1 Targeted drug delivery via phosphonate derivatives |
| 01/14/1992 | WO1992000761A1 Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance |
| 01/14/1992 | WO1992000725A1 Liquid oral pharmaceutical compositions having anti-inflammatory activity |
| 01/14/1992 | US5081153 Metaclopramide as antiemetic for cancer chemotherapy |
| 01/14/1992 | US5081150 Calcium lactate-glycerol adduct, a process for its preparation |
| 01/14/1992 | US5081111 Maleic anhydride-polyalkylene glycol ether copolymer modified by a perfume, growth regulator, vitamin, hormone, insect attractant, glycoside |
| 01/14/1992 | US5080908 Vitamin b12 composition |